Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d264574eb039dc96395529fc0d957a03 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0478 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14212 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172 |
filingDate |
2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf67c955b03d5c884387da5eabf7cfe |
publicationDate |
2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016296698-A1 |
titleOfInvention |
System for managing anti-coagulant infusions in patients |
abstract |
An anti-coagulant maintenance system for use in the treatment of patients with deep-vein thrombosis (DVT), pulmonary embolism (PE), Acute Coronary Syndrome, need for prophylactic anticoagulation or another related condition. The system establishes and adjusts the dosing of an anti-coagulant based upon periodic blood testing of a system specified frequency. Warning or alert messages or signals are produced if blood tests are not performed and a dosage adjustment is made based upon a coagulation test result outside of an established normal range. It is particularly useful for patients in a hospital or in-patient environment. |
priorityDate |
2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |